India’s Decision on Gleevec®: Implications for the Future
Eye on Washington: Gail R. Wilensky
India’s Supreme Court recently rejected a request from Novartis for a second patent for its cancer drug Gleevec. Forty other count...
*Please Login to read the the full content... *
Publication Date: Wednesday, May 01, 2013